(NYSE: ALB) Albemarle's forecast annual revenue growth rate of 6.75% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 5.56%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.71%.
Albemarle's revenue in 2025 is $4,946,415,000.On average, 27 Wall Street analysts forecast ALB's revenue for 2025 to be $592,960,206,520, with the lowest ALB revenue forecast at $561,888,055,960, and the highest ALB revenue forecast at $640,627,710,220. On average, 27 Wall Street analysts forecast ALB's revenue for 2026 to be $629,917,234,080, with the lowest ALB revenue forecast at $454,430,201,940, and the highest ALB revenue forecast at $725,605,334,100.
In 2027, ALB is forecast to generate $719,955,852,180 in revenue, with the lowest revenue forecast at $571,774,649,320 and the highest revenue forecast at $946,288,221,600.